Ekso Bionics/$EKSO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ekso Bionics
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
Ticker
$EKSO
Sector
Primary listing
Employees
64
Headquarters
Website
Ekso Bionics Metrics
BasicAdvanced
$8.7M
-
-$6.58
0.89
-
Price and volume
Market cap
$8.7M
Beta
0.89
52-week high
$5.60
52-week low
$2.73
Average daily volume
108K
Financial strength
Current ratio
2.379
Quick ratio
1.456
Long term debt to equity
33.788
Total debt to equity
49.323
Interest coverage (TTM)
-44.18%
Profitability
EBITDA (TTM)
-10.544
Gross margin (TTM)
51.52%
Net profit margin (TTM)
-75.66%
Operating margin (TTM)
-82.62%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
-30.17%
Return on equity (TTM)
-96.44%
Valuation
Price to revenue (TTM)
0.393
Price to book
0.8
Price to tangible book (TTM)
1.39
Price to free cash flow (TTM)
-0.626
Free cash flow yield (TTM)
-159.72%
Free cash flow per share (TTM)
-5.351
Growth
Revenue change (TTM)
-19.32%
Earnings per share change (TTM)
-43.61%
3-year revenue growth (CAGR)
3.65%
10-year revenue growth (CAGR)
7.87%
3-year earnings per share growth (CAGR)
-24.76%
10-year earnings per share growth (CAGR)
-31.86%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ekso Bionics stock?
Ekso Bionics (EKSO) has a market cap of $8.7M as of August 22, 2025.
What is the P/E ratio for Ekso Bionics stock?
The price to earnings (P/E) ratio for Ekso Bionics (EKSO) stock is 0 as of August 22, 2025.
Does Ekso Bionics stock pay dividends?
No, Ekso Bionics (EKSO) stock does not pay dividends to its shareholders as of August 22, 2025.
When is the next Ekso Bionics dividend payment date?
Ekso Bionics (EKSO) stock does not pay dividends to its shareholders.
What is the beta indicator for Ekso Bionics?
Ekso Bionics (EKSO) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.